PROCEPT BioRobotics Corp financial data

Symbol
PRCT on Nasdaq
Location
150 Baytech Drive, San Jose, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 829 % +2.08%
Quick Ratio 113 % +14.2%
Debt-to-equity 36.8 % -17.2%
Return On Equity -23.7 % +37.3%
Return On Assets -17.3 % +33.8%
Operating Margin -33.4 % +46.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.6M shares +7.13%
Common Stock, Shares, Outstanding 55.6M shares +7.09%
Entity Public Float 3.1B USD +121%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 55.4M shares +7.41%
Weighted Average Number of Shares Outstanding, Diluted 55.4M shares +7.41%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 275M USD +55.7%
Cost of Revenue 98.5M USD +23.2%
Research and Development Expense 65.7M USD +16%
Operating Income (Loss) -91.8M USD +16.3%
Net Income (Loss) Attributable to Parent -84.1M USD +18.9%
Earnings Per Share, Basic -1 USD/shares +25.2%
Earnings Per Share, Diluted -1 USD/shares +25.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 303M USD +41.4%
Accounts Receivable, after Allowance for Credit Loss, Current 80.8M USD +37.2%
Inventory, Net 67M USD +52.8%
Assets, Current 458M USD +42.3%
Property, Plant and Equipment, Net 28.6M USD +3.35%
Operating Lease, Right-of-Use Asset 18.3M USD -6.76%
Other Assets, Noncurrent 4.29M USD +293%
Assets 513M USD +37.1%
Accounts Payable, Current 11.8M USD +18.4%
Contract with Customer, Liability, Current 9.89M USD +50.9%
Liabilities, Current 49.7M USD +16.1%
Contract with Customer, Liability, Noncurrent 517K USD
Operating Lease, Liability, Noncurrent 25.8M USD -7.4%
Other Liabilities, Noncurrent 223K USD -53.4%
Liabilities 127M USD +3.82%
Accumulated Other Comprehensive Income (Loss), Net of Tax -144K USD -14300%
Retained Earnings (Accumulated Deficit) -590M USD -16.6%
Stockholders' Equity Attributable to Parent 386M USD +53.2%
Liabilities and Equity 513M USD +37.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17M USD +47.4%
Net Cash Provided by (Used in) Financing Activities 1.3M USD -49.8%
Net Cash Provided by (Used in) Investing Activities -1.84M USD +5.65%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 55.6M shares +7.09%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.5M USD +44.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 306M USD +40.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 885K USD -11.9%
Deferred Tax Assets, Valuation Allowance 156M USD +28.6%
Deferred Tax Assets, Gross 161M USD +27.2%
Operating Lease, Liability 27.8M USD -5.97%
Payments to Acquire Property, Plant, and Equipment 1.84M USD -5.65%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -84.3M USD +18.7%
Lessee, Operating Lease, Liability, to be Paid 38.6M USD -9.88%
Property, Plant and Equipment, Gross 39.2M USD +16.8%
Operating Lease, Liability, Current 2.06M USD +16.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.81M USD +8.63%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.43M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.8M USD -18.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.95M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 96.5M USD +20.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.72M USD +39.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.1M USD +3.01%
Additional Paid in Capital 976M USD +28.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.48M USD +24.6%
Deferred Tax Assets, Net of Valuation Allowance 4.66M USD -6.09%
Share-based Payment Arrangement, Expense 39.9M USD +62.4%
Interest Expense 4.15M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%